Need quick answers about Procardia XL’s pharmacokinetics? Procardia XL (nifedipine extended-release) typically reaches peak plasma concentrations within 6-8 hours after oral administration. This extended-release formulation provides a slower and more sustained release of nifedipine compared to immediate-release versions, leading to a longer duration of action.
The duration of action extends for up to 24 hours, providing consistent blood pressure control. However, individual responses vary. Factors such as liver and kidney function, age, and other medications significantly influence absorption and elimination rates. Always consult your physician or pharmacist for personalized guidance.
Remember: This information serves as a general overview and should not replace professional medical advice. Never adjust your medication dosage without consulting a healthcare professional. They can assess your specific needs and determine the appropriate dosage and administration schedule for optimal therapeutic effects and minimized side effects. Precise onset, peak, and duration data may also vary depending on the specific formulation and individual patient factors.
Always prioritize safety: If you experience any adverse effects, report them immediately to your doctor. This includes but isn’t limited to: headaches, dizziness, flushing, nausea, or ankle swelling.
